We further validated its upregulation via qRT-PCR analysis in MCF-7.TamR and T47D.TamR cells, a second tamoxifen-resistant ER+ breast cancer cell line that we developed [33] compared to parental cells (Fig. 1B). The gene discussed is ESR1; the disease is breast carcinoma.